Patents by Inventor James Coghill

James Coghill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11927553
    Abstract: An apparatus for bulk ore sorting using gamma activation analysis is disclosed. The apparatus includes a conveyor system that includes one or more conveyor belts, surrounded by one or more radiation shields, to transport ore material along a transport path. A pulsed X-ray radiation source is configured to irradiate ore material at an irradiation region and one or more detectors are configured to detect a gamma radiation output from irradiated ore material at a detection region. The transport path has a bend, located between the irradiation region and the detection region, and about a vertical axis, of at least 45 degrees. The one or more detectors are configured to detect a radiation output from the irradiated ore material at times between X-ray pulses of the pulsed X-ray radiation source irradiating the ore material.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: March 12, 2024
    Assignee: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
    Inventors: Peter Coghill, James Tickner, Chanel Tissot, Ian Carter, Nicholas Cutmore
  • Publication number: 20230285386
    Abstract: A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.
    Type: Application
    Filed: May 18, 2023
    Publication date: September 14, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Peter MACK, Dustin MELTON, Bethany Amber DOTY, Jon SCHROEDER, James COGHILL, Daniel Emil LEVY
  • Publication number: 20230107398
    Abstract: A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.
    Type: Application
    Filed: December 7, 2022
    Publication date: April 6, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Peter MACK, Dustin MELTON, Bethany Amber DOTY, Jon SCHROEDER, James COGHILL, Daniel Emil LEVY
  • Publication number: 20230064429
    Abstract: A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.
    Type: Application
    Filed: August 17, 2022
    Publication date: March 2, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Peter MACK, Dustin MELTON, Bethany Amber DOTY, Jon SCHROEDER, James COGHILL
  • Patent number: 11471517
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: October 18, 2022
    Assignees: The University of North Carolina at Chapel Hill, Regents of the University of Minnesota
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent
  • Publication number: 20200155656
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Application
    Filed: October 10, 2019
    Publication date: May 21, 2020
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent
  • Publication number: 20170360907
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Application
    Filed: December 4, 2015
    Publication date: December 21, 2017
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent
  • Publication number: 20130116244
    Abstract: The present invention provides a powder composition for the buccal delivery comprising a drug compound, a muco-adhesive agent and a dispersing agent Suitable compounds drugs include benzodiazepine compounds. Suitable muco-adhesive agents include those selected from (t) esters and salts of alginic acid and (it) hydroxyethyl cellulose. Suitable dispersing agents include those selected from ethylene oxide-propylene oxide copolymers.
    Type: Application
    Filed: April 28, 2011
    Publication date: May 9, 2013
    Applicant: AESICA FORMULATION DEVELOPMENT LIMITED
    Inventors: James Coghill, Robert Armstrong
  • Publication number: 20130102998
    Abstract: A holder for a drug delivery device comprising a body portion, and a first flange extending from the holder, wherein the body portion comprises a receiving portion for receiving a drug delivery device, and the flange extends from the body portion of the holder.
    Type: Application
    Filed: April 28, 2011
    Publication date: April 25, 2013
    Applicant: AESICA FORMULATION DEVELOPMENT LIMITED
    Inventors: James Coghill, Robert Armstrong
  • Patent number: D697201
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: January 7, 2014
    Assignee: R5 Pharmaceuticals Limited
    Inventors: James Coghill, Robert Armstrong